Menu
1-702-720-6310 info@microcapspecualtors.com

Is Exelixis the Best Small-Cap Biotech Stock? – Fox Business


Fox Business

Is Exelixis the Best Small-Cap Biotech Stock?
Fox Business
What stock is “best” is undeniably subjective, but Exelixis’ (NASDAQ: EXEL) 196% return this year certainly makes it worthy of consideration. Continue Reading Below. Shares in the once-maligned cancer drug developer have enjoyed a resurgence this year …

and more »

Search